Literature DB >> 17425937

Case-control study on feed risk factors for BSE cases born after the feed ban in France.

Nathalie Jarrige1, Christian Ducrot, Géraldine Cazeau, Eric Morignat, Claude La Bonnardière, Didier Calavas.   

Abstract

In France, after the ban on meat and bone meal (MBM) in cattle feeding in June 1990, cases of Bovine Spongiform Encephalopathy (BSE) have continued to be detected in bovines born after that ban (called BAB cases). A case-control study was therefore carried out to determine the way these cases were contaminated. A multivariate conditional model was built adjusting for the production type of the animals and taking into account the herd size. The results confirmed that feeding cattle with proprietary concentrates was at risk for BSE, with an adjusted odds ratio of 6.8 (2.5; 18.7) for the consumption of less or three different proprietary concentrates and 17.6 (5.7; 54.8) for more than three, when comparing with no consumption of proprietary concentrates, considering feeding of bovines before the age of two. The results suggest that cross-contaminations by MBM in bovine concentrates have occurred after 1990. To a lesser extent, on-farm cross-contaminations, i.e. consumption by cattle of feedstuffs initially dedicated to other animals and which could legally contain MBM, have probably also existed, since the presence on farms of poultry fed purchased feed involved an increased risk of BSE with an odds ratio of 1.8 (1.1; 3.0). The use of milk replacers, which often incorporates animal fats, was also at risk with an odds ratio of 1.8 (1.0; 3.1).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425937     DOI: 10.1051/vetres:2007011

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  1 in total

1.  Milk replacers and bovine spongiform encephalopathy in calves, Japan.

Authors:  Toshiyuki Tsutsui; Takehisa Yamamoto; Sayaka Hashimoto; Takashi Nonaka; Akiko Nishiguchi; Sota Kobayashi
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.